matrixx initiatives

Matrixx Initiatives, Inc. (MTXX). F2Q10 (Qtr End 09/30/09) Earnings Call Transcript. October 27, 2009 11:00 am ET. Complete Story » Go to Source.Matrixx Initiatives Inc. Beats Analyst Expectations; MTXX, GNBT, BVF. Advertisement: read more.Analysts were expecting Matrixx Initiatives Inc. (MTXX) [Chart - News - Analysis] to report earnings of $0.30 for last quarter, but MTXX beat expectations with actual earnings of $0.55---25 cents ... Related Symbols: NASDAQ:GNBT.Reuters -- Matrixx Initiatives Inc said the US health regulator has indicated that it is unwilling to reverse its position regarding the warning letter issued on company's nasal versions of Zicam cold remedy.26 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam® products, today announced financial results for its fiscal second quarter and six months ...According to Matrixx Initiatives, Inc., maker of Zicam cold remedy, the FDA is not going to reverse a prior stance that prevents the company from marketing the over-the-counter homeopathic remedy due to reports of consumers losing their ...FDA inspectors later determined that Matrixx Initiatives improperly withheld 800 reports of Zicam problems, which should have been turned over to the federal regulatory agency. New Zicam class actions were filed this year against ...Matrixx Initiatives, Inc., Case No. 06-15677 (9th Cir. Oct. 28, 2009) is a class action brought against the pharmaceutical company that sells the cold remedy Zicam. The complaint claims that the company failed to disclose material ...Long term, technical analysis chart of MTXX stock (Matrixx Initiatives, Inc - NASDAQ:MTXX), with trend lines and support/resistance levels: MTXX - Matrixx Initiatives - Long term stock chart, 1996 - 2009 MTXX - Matrix Initiatives - Long ...Matrixx Initiatives, Inc. Reports Fiscal 2010 Second Quarter Sales and Net Income Reuters The lower sales in the quarter ended September 30, 2009 versus the prior year is primarily attributable to the loss of nasal Cold Remedy products, ...